Phase 2 significant effects. by Wendy C. Crone (2262169)

Phase 1 significant effects. by Wendy C. Crone (2262169)

Frequencies for biggest concerns. by Ma. Teresa Tuason (10305328)

Subjects:

Significantly changed USS in the <i>sf3b1</i> mutants. by Bei Zhang (428038)

Significantly changed AS events in the <i>sf3b1</i> mutants. by Bei Zhang (428038)

After moderate and severe TBI, PWI revealed CBF was significantly decreased in the ipsilateral cortex and hippocampus at several time points relative to sham animals. by Juliana Sanchez-Molano (16792787)

Results of Analysis of Co-variance (ANCOVA) for change in parameter predicted by treatment group with pre-treatment value as a covariate. * p < 0.05; ** p < 0.01. by Lijuan Liu (136685)

Subjects:

Average annual change, 95% confidence interval and significance for sum concentrations of different compound groups. by Matti Viluksela (321291)

Transcriptional and translational markers of syncytialization and biochemical differentiation are significantly decreased by rotenone. by O’Llenecia S. Walker (8486163)

<i>PAB1</i> gene deletion significantly decrease mRNA and protein levels of many translation- and RNA binding-related genes. by Kotchaphorn Mangkalaphiban (9767180)

Strengths and concerns. by Vivek Astvansh (14310090)

The variation trend of |BD| value with age: With the increase of age, the |BD| values decreased significantly (p<0.01). by Yunmeng Da (707943)

County-level geographical septile distribution for the first 12 statistically significant factors with at least one statistically significant coefficient ranked by decreasing ΔIC. by Yanan Long (11784717)

Apoptotic gene expression without significant changes induced by propofol. by Yali Ge (417371)

Number of participants showing improved, decreased, or no change in task performance with and without PSAPs. by Maxime Perron (16618003)

A: Bacteria species/ASVs exhibiting a significant change in relative abundance after exposure to sodium sulfite. by Sally V. Irwin (4521733)

Subjects:

Estimated average absolute and relative changes from the no-policy counterfactual by phase and high-in status. by Lindsey Smith Taillie (3159258)

Subjects:

Estimated average absolute and relative changes from the no-policy counterfactual by phase and beverage group. by Lindsey Smith Taillie (3159258)

Subjects:

Estimated average absolute and relative changes from the no-policy counterfactual by phase and food group. by Lindsey Smith Taillie (3159258)

Subjects:

GO analysis of stage-salient genes in the order of decreasing significance (i.e, increasing p–value). by Sangeetha Muthamilselvan (8966006)